![]() ![]() These results support lopinavir therapeutic drug monitoring and the use of higher lopinavir doses for PI-pretreated patients. The probability to achieve the 4 and 5.7 mg/l target C(troughs) with the twice-daily dose significantly decreased when body weight increased (from 76% to 61% and from 56% to 37% respectively, for body weights increasing from 50 to 90 kg). Facebook gives people the power to share and makes. Probability to achieve the 1 mg/l target C(trough) was >96% for the twice-daily dose and comprised between 80% and 90% for the once-daily dose. Join Facebook to connect with Laurence Dupin and others you may know. Authors: Pierre Marcasuzaa, Samuel Pearson, Karell Bosson, Laurence Pessoni, Jean-Charles Dupin, Laurent Billon. Body weight was found to explain the interindividual variability of lopinavir CL/F. Parcours Parcours scolaire Ecole Georges Tanchoux - La baule escoublac 1992 - 1996 Collge. Mean population estimates (percentage interindividual variability) were 4.61 l/h (36%) for apparent clearance (CL/F) and 63.2 l (70%) for apparent distribution volume. Pour la contacter, connectez-vous ou inscrivez-vous gratuitement. Incontournables Bcpst pdf Lindsey Fraser Rencontre Avec J K Rowling pdf Laurence Dujardin Les 50 R Gles Dor pdf Td corrig Popular pdfs in France on 18 01 2011 Examen April 22nd, 2020 - Popular pdfs in. However, the probability to achieve these target C(troughs) with the current 400 mg twice-daily or 800 mg once-daily doses of the new tablet form, and the influence of body weight on this probability are unknown.Ī population pharmacokinetic model for lopinavir was developed using data from 424 HIV type-1-infected patients, and the final model was used to estimate the probability to achieve target C(troughs) via Monte Carlo simulations.Ī one-compartment model adequately described the data. Michel Dupin Jean Luc Schneider Marc Tardy Cécile Van Der Rest Conforme au programme de BCPST 1re et 2e années, cet ouvrage tout en couleur. Different lopinavir target trough concentrations (C(troughs)) were previously determined according to patient treatment histories: 1 mg/l for PI-naive patients, and 4 and 5.7 mg/l for PI-experienced patients. Lopinavir is a potent protease inhibitor (PI) used for the treatment of HIV infection. Generalized Dupin Cyclides with Rational Lines of Curvature Martin Peternell Institute of Discrete Mathematics. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |